EcoR1 Capital, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
EcoR1 Capital, LLC disclosed 63 US equity positions worth $2.9bn in its Q3 2024 13F filing. The largest position was APLSUSD at 11.7% of the reported book, followed by ANAB and CRNXGBP.
What did EcoR1 Capital, LLC own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | APLSUSD APELLIS PHARMACEUTICALS INC | 11.7% | $342.9m | 11,890,843 | – | ||
| 2 | ANAB ANAPTYSBIO INC | Healthcare | 8.9% | $261.1m | 7,794,996 | – | |
| 3 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 7.5% | $219.1m | 4,288,120 | – | ||
| 4 | PROTHENA CORP PLC | 6.6% | $193.8m | 11,584,280 | – | ||
| 5 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 6.5% | $190.1m | 1,706,469 | – | |
| 6 | ZYME ZYMEWORKS INC | Healthcare | 5.8% | $168.6m | 13,437,473 | – | |
| 7 | ARVN ARVINAS INC | Healthcare | 5.7% | $165.7m | 6,726,491 | – | |
| 8 | KURA KURA ONCOLOGY INC | Healthcare | 3.9% | $113.5m | 5,806,871 | – | |
| 9 | XNCR XENCOR INC | Healthcare | 3.7% | $107.2m | 5,330,416 | – | |
| 10 | TNGX TANGO THERAPEUTICS INC | Healthcare | 3.5% | $102.6m | 13,330,736 | – | |
| 11 | JANX JANUX THERAPEUTICS INC | Healthcare | 2.3% | $66.8m | 1,469,818 | – | |
| 12 | CRSP CRISPR THERAPEUTICS AG | Healthcare | 2.2% | $65.3m | 1,389,276 | – | |
| 13 | IMNM IMMUNOME INC | Healthcare | 1.9% | $56.7m | 3,879,415 | – | |
| 14 | NGNE NEUROGENE INC | 1.8% | $53.3m | 1,271,342 | – | ||
| 15 | CNTA CENTESSA PHARMACEUTICALS PLC | 1.8% | $51.5m | 3,223,851 | – | ||
| 16 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 1.5% | $44.6m | 1,958,847 | – | |
| 17 | NUVB NUVATION BIO INC | Healthcare | 1.5% | $44.0m | 19,209,643 | – | |
| 18 | THIRD HARMONIC BIO INC | 1.5% | $43.1m | 3,182,444 | – | ||
| 19 | PCVX VAXCYTE INC | Healthcare | 1.4% | $40.3m | 352,464 | – | |
| 20 | MERSANA THERAPEUTICS INC | 1.3% | $36.6m | 19,364,688 | – | ||
| 21 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.2% | $35.0m | 3,418,068 | – | |
| 22 | RNAGBP AVIDITY BIOSCIENCES INC | 1.2% | $34.8m | 757,576 | – | ||
| 23 | EWTX EDGEWISE THERAPEUTICS INC | 1.1% | $33.4m | 1,250,385 | – | ||
| 24 | MBX MBX BIOSCIENCES INC | Healthcare | 1.0% | $30.5m | 1,175,809 | – | |
| 25 | NMRA NEUMORA THERAPEUTICS INC. | Healthcare | 0.9% | $27.4m | 2,071,450 | – | |
| 26 | CRGX CARGO THERAPEUTICS INC | 0.9% | $27.1m | 1,470,000 | – | ||
| 27 | ADAPY ADAPTIMMUNE THERAPEUTICS PLC | Healthcare | 0.9% | $26.0m | 27,404,070 | – | |
| 28 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.9% | $25.7m | 849,143 | – | |
| 29 | TCRX TSCAN THERAPEUTICS INC | 0.9% | $24.9m | 5,000,000 | – | ||
| 30 | VYGR VOYAGER THERAPEUTICS INC | Healthcare | 0.8% | $22.9m | 3,917,546 | – | |
| 31 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 0.8% | $22.1m | 650,000 | – | |
| 32 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 0.7% | $20.6m | 910,000 | – | |
| 33 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 0.7% | $20.0m | 500,000 | – | |
| 34 | DYN DYNE THERAPEUTICS INC | Healthcare | 0.7% | $20.0m | 555,644 | – | |
| 35 | AVIR ATEA PHARMACEUTICALS INC | Healthcare | 0.6% | $18.2m | 5,441,896 | – | |
| 36 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.6% | $17.7m | 2,500,000 | – | |
| 37 | PHVS PHARVARIS N V | 0.6% | $16.7m | 900,000 | – | ||
| 38 | 2662247D ITEOS THERAPEUTICS INC | 0.6% | $16.4m | 1,608,616 | – | ||
| 39 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.5% | $15.9m | 75,000 | – | |
| 40 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.4% | $12.0m | 862,068 | – | ||
| 41 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.4% | $10.9m | 187,500 | – | |
| 42 | REPL REPLIMUNE GROUP INC | Healthcare | 0.3% | $9.3m | 850,341 | – | |
| 43 | ALLOVIR INC | 0.3% | $9.1m | 11,294,585 | – | ||
| 44 | LENZ LENZ THERAPEUTICS INC | Healthcare | 0.3% | $8.2m | 346,772 | – | |
| 45 | VERVE THERAPEUTICS INC | 0.2% | $6.0m | 1,250,000 | – | ||
| 46 | GBIOGBX GENERATION BIO CO | 0.2% | $5.1m | 2,046,867 | – | ||
| 47 | LKFT GALAPAGOS NV | Healthcare | 0.2% | $4.5m | 155,006 | – | |
| 48 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.1% | $4.3m | 170,172 | – | |
| 49 | ATRA ATARA BIOTHERAPEUTICS INC | 0.1% | $3.8m | 468,938 | – | ||
| 50 | WHWK AADI BIOSCIENCE INC | Healthcare | 0.1% | $3.8m | 1,845,253 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.